Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Which Oral Combination of Anti-diabetes Medication May Work Better in Subjects With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: a Randomized Control Trial

NCT04976283 is registered in ClinicalTrials.gov with Getz Pharma as lead sponsor.

NCT NCT04976283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04976283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Which Oral Combination of Anti-diabetes Medication May Work Better in Subjects With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: a Randomized Control Trial
Lead sponsor
Getz Pharma
Phase
Phase 4
Overall status
Unknown status
Start date
September 15, 2021
Completion date
November 15, 2023
Enrollment
123 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, nafld, nash - nonalcoholic steatohepatitis